Case of possible encephalopathy following receiving the first dose of Iranian COVID-19Vaccine; COVIran Barakat

Mohammad Javad Fallahi; Navid Esmaeilzadeh Shahri; Zohre Khodamoradi; Moazameh Meymandi Nia; Faezeh Sehatpour; Laleh Mahmoudi

doi:10.1002/ccr3.5661

Case of possible encephalopathy following receiving the first dose of Iranian COVID-19Vaccine; COVIran Barakat

Clin Case Rep. 2022 Apr 7;10(4):e05661. doi: 10.1002/ccr3.5661. eCollection 2022 Apr.

Authors

Mohammad Javad Fallahi¹, Navid Esmaeilzadeh Shahri², Zohre Khodamoradi¹, Moazameh Meymandi Nia¹, Faezeh Sehatpour¹, Laleh Mahmoudi²

Affiliations

¹ Department of internal medicine Shiraz University of Medical Sciences Shiraz Iran.
² Department of Clinical Pharmacy School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran.

Abstract

We report a case of possible encephalopathy after receiving the first dose of Iran's COVIran Barekat vaccine. The patient had no history of neurological or mental illness. Clinical examinations and radiology reports were performed and differential diagnoses were analyzed by the treatment team. Finally, the possible association between vaccination and encephalopathy was concluded.

Keywords: COVID‐19; COVIran Barekat; encephalopathy; vaccine.

Publication types

Case Reports